Symposium overview: Estrogens and antiestrogens in managing the patient with breast cancer |
| |
| Authors: | Lisa A Newman MD William C Wood MD Rena V Sellin MD Monica Morrow MD Charles Vogel MD S Eva Singletary MD |
| |
| Institution: | (1) Department of Surgical Oncology, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Blvd., Box 106, 77030 Houston, TX;(2) Endocrine Neoplasia, The University of Texas M. D. Anderson Cancer Center, Houston, TX;(3) Department of Surgery, Emory University School of Medicine, USA;(4) Department Cancer Research, Columbia Cancer Research Network of Florida, Aventura, FL;(5) Department of Surgery, Northwestern University, Chicago, IL |
| |
| Abstract: | The prevalence of breast cancer (a hormonally driven neoplasm) in the United States, the potential health benefits of estrogen
replacement therapy for postmenopausal women, and the burgeoning research focusing on selective estrogen receptor modulators
(SERMs) have resulted in additional complexity in managing breast cancer. In an attempt to clarify existing data, the Society
of Surgical Oncology sponsored a symposium entitled “Estrogens and Antiestrogens in Managing the Patient with Breast Cancer”
at its 52nd Annual Cancer Symposium. This conference was held in March 1999 and was chaired by Dr. S. Eva Singletary, Professor
of Surgery and Chief of the Surgical Breast Section at The University of Texas M. D. Anderson Cancer Center in Houston, Texas.
The following is a review of the material presented by the symposium participants. |
| |
| Keywords: | Breast cancer Antiestrogen |
| 本文献已被 PubMed SpringerLink 等数据库收录！ |
|
